Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Hematopoiesis-stimulating compounds from Nycomed Pharma

Aug. 23, 1996

RIIbeta: Potential antiobesity drug target

Aug. 23, 1996

CCK-A agonist from Glaxo Wellcome

Aug. 23, 1996

New hypolipidemic agent from Schering-Plough

Aug. 23, 1996

Metachol distribution agreement

Aug. 23, 1996

Eisai's squalene synthase inhibitor and prodrug

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Indian hedgehog molecule's role in cartilage and bone development

Aug. 23, 1996

Osteocalcin study findings reported

Aug. 23, 1996

Aredia earns U.S. approval for new indication

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...